Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: 203Pb/212Pb is a promising theranostics pair for SSTR2-targeted alpha-particle therapy for neuroendocrine tumors (NETs). The development of SSTR2-targeted peptides that are optimized for the Pb isotopes has the potential to improve performance.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Lee D, Li M, Baumhover N, Liu D, Sagastume E,
Keywords: prrt, VMT-alpha-NET, 203Pb/212Pb theranostics,
#2962 90Y- and/or 177Lu-DOTATOC Re-Challenge in Patients with Progressive Neuroendocrine Tumors
Introduction: Most patients treated with PRRT will eventually progress. Previous studies indicated that repeated PRRT is feasible and promising.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Aberle S
Authors: Aberle S, Benz M, Grokovski R, Christ E, Nicolas G,
Keywords: PRRT, Re-challenge, 90Y-DOTATOC, 177Lu-DOTATOC, neuroendocrine tumor,
Introduction: Metabolic changes are observed in early and late stages of Pancreatic Neuroendocrine Tumors (PanNET) in mouse models. In human PanNET, RNA-expression analysis showed changes in glucose metabolism in more aggressive PanNET.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Bräutigam K
Authors: Straub J, Bräutigam K, Di Domenico A, Galván J, Maire R,
Keywords: metabolism, microadenoma, immunohistochemistry, pancreas, tumor, mct4, relapse,
Introduction: Progression-free survival (PFS) has been used as surrogate endpoint in phase III trials with somatostatin analogues for gastroentero-pancreatic neuroendocrine tumors (GEP-NET). However, this endpoint has not been validated in this scenario.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Jimenez Fonseca P
Authors: Jimenez-Fonseca P, Carmona-Bayonas A, Lamarca A, Barriuso J, Castaño A,
Keywords: somatostatin analogues, surrogate, PFS, OS, correlation, kendall,
Introduction: The absence of an accurate blood biomarker to predict and monitor PRRT is a key unmet need.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Bodei L
Authors: Bodei L, Kidd M, Singh A, van der Zwan W, Severi S,
Keywords: biomarker, PRRT, prediction, NETest, PPQ, CgA, personalized medicine,